Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2025
  • July
  • Page 19
trinity-biotech-outlines-plans-for-wearable-cgm+-biosensor-platform
Posted inMedical Technology

Trinity Biotech outlines plans for wearable CGM+ biosensor platform

July 24, 2025
Clinical diagnostic developer Trinity Biotech intends to enter the personal diabetes management market with a planned wearable continuous glucose monitor…
Read More
novartis-puts-$1b-on-the-line-to-court-preclinical-biotech-matchpoint
Posted inBiotechnology

Novartis puts $1B on the line to court preclinical biotech Matchpoint

July 24, 2025
Novartis is serving up $60 million to partner with Matchpoint Therapeutics in hopes of getting an oral covalent inhibitor over…
Read More
bio-usawa-biotech-and-servaregmp-form-partnership-to-advance-accessible-biotherapeutic-manufacturing-in-africa
Posted inGenetics

Bio Usawa Biotech and ServareGMP Form Partnership to Advance Accessible Biotherapeutic Manufacturing in Africa

July 24, 2025
Bio Usawa Biotechnology and ServareGMP formed a strategic partnership to establish advanced monoclonal antibody (mAb) manufacturing capabilities in Africa, directly…
Read More
orthopedic-implant-maker-shoulder-innovations-sets-terms-for-$100m+-ipo
Posted inMedical Technology

Orthopedic implant maker Shoulder Innovations sets terms for $100M+ IPO

July 24, 2025
The orthopedic implant maker Shoulder Innovations is the latest medtech to plan for a nine-figure IPO, as it looks to…
Read More
galapagos-builds-island-of-cell-therapies-to-prep-for-potential-sale-amid-pipeline-pruning
Posted inBiotechnology

Galapagos builds island of cell therapies to prep for potential sale amid pipeline pruning

July 24, 2025
After ditching a plan to split into two distinct companies, Belgian biotech Galapagos is trimming its pipeline and consolidating cell…
Read More
cell-therapy-biotech-adicet-turns-to-autoimmune,-shedding-a-phase-1-asset-and-30%-of-staffers
Posted inBiotechnology

Cell therapy biotech Adicet turns to autoimmune, shedding a phase 1 asset and 30% of staffers

July 24, 2025
Adicet Bio is handing out pink slips to 30% of its staffers in tandem with a pipeline restructure that includes…
Read More
rocket-adjusts-trajectory,-laying-off-30%-of-staff-and-narrowing-pipeline-focus
Posted inBiotechnology

Rocket adjusts trajectory, laying off 30% of staff and narrowing pipeline focus

July 24, 2025
Rocket Pharmaceuticals is laying off 30% of its staff and focusing on its cardiovascular disease programs, causing delays to assets including…
Read More
astrazeneca’s-blockbuster-contender-hits-phase-3-goals,-fueling-myasthenia-gravis-fight
Posted inBiotechnology

AstraZeneca’s blockbuster contender hits phase 3 goals, fueling myasthenia gravis fight

July 24, 2025
A phase 3 study of AstraZeneca’s gefurulimab has hit its primary and all secondary endpoints, teeing up talks with regulators about…
Read More
roche-axes-carmot-obesity-asset,-3-cancer-drugs-in-r&d-clear-out
Posted inBiotechnology

Roche axes Carmot obesity asset, 3 cancer drugs in R&D clear-out

July 24, 2025
Roche has axed one of the obesity assets from its $2.7 billion Carmot Therapeutics buyout, sending the molecule to the scrap…
Read More
nearly-complete-human-genomes-reveal-complex-genetic-variation
Posted inGenetics

Nearly Complete Human Genomes Reveal Complex Genetic Variation

July 24, 2025
Structural variants (SVs) are alterations in the DNA sequence that involve large-scale changes, typically longer than 50 base pairs. Advances…
Read More

Posts pagination

Previous page 1 … 17 18 19 20 21 … 61 Next page

Privacy Policy    Terms

Scroll to Top